Waldman Louis S. 4

4 · IRADIMED CORP · Filed Feb 14, 2020

Form 4

Period: 2020-02-12

Controller

Transactions

Sale
Common Stock
2020-02-12$25.48/sh−4,307$109,742→ 0 total
Exercise/Conversion
Common Stock
2020-02-12$1.29/sh+8,750$11,288→ 8,750 total
Exercise/Conversion
Common Stock
2020-02-12$1.29/sh+17,500$22,575→ 26,250 total
Exercise/Conversion
Common Stock
2020-02-12$1.48/sh+8,750$12,950→ 35,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-02-12+8,750→ 0 total
Exercise: $1.29→ Common Stock (8,750 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-02-12+17,500→ 0 total
Exercise: $1.29→ Common Stock (17,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-02-12+8,750→ 0 total
Exercise: $1.48→ Common Stock (8,750 underlying)

Footnotes (4)

[F1]This transaction was executed in multiple trades at prices ranging from $25.43 to $25.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]This option was granted on 11/20/2012 and is fully vested and exercisable.
[F3]This option was granted on 12/13/2013 and is fully vested and exercisable.
[F4]This option was granted on 12/31/2013 and is fully vested and exercisable.

Documents

1 file